TRENDS

Drug Formulary Initiatives Moving Beyond Hospitals, Generic Makers Prepping for Regional Lists

By Reiji Anasako January 30, 2019

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

Initiatives to draw up formularies, or preferred drug lists, are extending beyond the walls of individual hospitals in Japan, with regional bodies starting to launch such efforts to utilize generics for cost controls. The move comes in tandem with the…

To read the full story

Chuikyo Reps Give Kudos to Formulary Initiatives, but Wary on Creating Medical Fees
June 27, 2019
Regional Formulary Initiatives Underway, Eyes on Cost Control for Branded Drugs with No Gx
January 22, 2019

TRENDS

Top 10 PHARMA JAPAN Articles of 2025
December 23, 2025
Top 10 PHARMA JAPAN Articles of 2024
December 25, 2024
Top 10 Most-Read PHARMA JAPAN Articles in 2023
December 28, 2023
Top 10 PHARMA JAPAN Articles in 2022
December 28, 2022
15 APIs with 10 Billion Yen-Plus Peak Sales Outlooks Listed in 2021: Jiho Tally
December 28, 2021

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Japan’s Biological Raw Material Rules Enter Major Revision; Clarity on Benefits and Safety Holds Key

By Sakura Kono

Japan is poised to make the most sweeping revision in eight years to the Standards for Biological Raw Materials —…

COLUMN

AI in Healthcare Hiring: Leveling the Playing Field & Unlocking Human Potential

By Philip Carrigan

The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…